Trexquant Investment LP Sells 40,720 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Trexquant Investment LP lessened its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 82.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,810 shares of the company's stock after selling 40,720 shares during the quarter. Trexquant Investment LP's holdings in Henry Schein were worth $610,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Versant Capital Management Inc increased its position in shares of Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after purchasing an additional 335 shares during the last quarter. Venturi Wealth Management LLC boosted its stake in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after buying an additional 569 shares in the last quarter. Quent Capital LLC grew its position in Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after acquiring an additional 323 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after acquiring an additional 143 shares in the last quarter. Finally, City State Bank bought a new stake in shares of Henry Schein in the 4th quarter worth approximately $55,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently commented on HSIC shares. Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and raised their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. UBS Group lowered their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Wells Fargo & Company began coverage on Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target on the stock. Finally, StockNews.com cut Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein currently has an average rating of "Moderate Buy" and a consensus price target of $81.10.

Insider Buying and Selling at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Trading Up 0.6 %

Shares of NASDAQ:HSIC traded up $0.38 on Thursday, hitting $63.67. The company had a trading volume of 210,525 shares, compared to its average volume of 1,603,343. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm's 50-day simple moving average is $70.95 and its two-hundred day simple moving average is $72.07. The firm has a market capitalization of $7.91 billion, a price-to-earnings ratio of 26.21, a P/E/G ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm's revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the company posted $0.66 EPS. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.